DKFZp779B1540 Activators
Chemical activators of DKFZp779B1540 can play a significant role in modulating its activity through various signaling pathways. Forskolin is known to directly stimulate adenylyl cyclase, which elevates the levels of cyclic AMP (cAMP) within the cell. The increase in cAMP leads to the activation of protein kinase A (PKA). When active, PKA can phosphorylate DKFZp779B1540, assuming it is a suitable substrate for this kinase, thereby enhancing its activity. Similarly, isoproterenol, a beta-adrenergic agonist, also increases cAMP levels by stimulating adenylyl cyclase via G-protein coupled receptors, potentially leading to the phosphorylation and activation of DKFZp779B1540 through PKA. In parallel, PMA, which is an activator of protein kinase C (PKC), may phosphorylate DKFZp779B1540 if it is a recognized substrate, leading to an increase in its activity. This activation process is shared by other compounds that influence different kinases, such as anisomycin, which activates stress-activated protein kinases (SAPKs) like JNK that can also target DKFZp779B1540 for phosphorylation.
Furthermore, the elevation of intracellular calcium levels is a common mechanism by which certain chemical activators exert their effects on DKFZp779B1540. Ionomycin acts as a calcium ionophore and can raise intracellular calcium, potentially activating calcium-dependent protein kinases that could phosphorylate DKFZp779B1540. Calcium chloride has a similar effect by increasing intracellular calcium levels, which may activate calcium-dependent kinases to phosphorylate and activate DKFZp779B1540. Thapsigargin, by inhibiting the SERCA pump, leads to increased cytosolic calcium levels, which can further promote the activation of DKFZp779B1540 through calcium-mediated signaling pathways. Additionally, insulin triggers the PI3K/AKT pathway, which can lead to the phosphorylation of various proteins, possibly including DKFZp779B1540, thereby modulating its activity. Epidermal Growth Factor (EGF) follows a related route by activating EGFR tyrosine kinase, setting in motion multiple signaling cascades that may result in the phosphorylation and subsequent activation of DKFZp779B1540. Lastly, sodium orthovanadate and okadaic acid both maintain the phosphorylation state of proteins by inhibiting phosphatases. Sodium orthovanadate inhibits protein tyrosine phosphatases, while okadaic acid targets protein phosphatases PP1 and PP2A, which can lead to the sustained activation of DKFZp779B1540 if it is subject to regulation by these phosphatases.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as an ionophore for calcium, elevating intracellular Ca2+ concentrations. This can activate calcium-dependent protein kinases, such as calmodulin-dependent kinase, which may phosphorylate and activate DKFZp779B1540 if it is recognized as a substrate by these kinases. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a variety of substrates. If DKFZp779B1540 is a PKC substrate, its activity can be increased upon phosphorylation by PKC. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can increase cAMP levels by activating adenylyl cyclase via G-protein coupled receptors, leading to activation of PKA. If DKFZp779B1540 is a target of PKA, this could result in its activation through phosphorylation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/AKT signaling pathway, which can result in the phosphorylation of various downstream proteins. If DKFZp779B1540 is part of this pathway or is a substrate for any kinase in this pathway, its activity can be increased through such phosphorylation events. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen peroxide can act as a signaling molecule, modulating the activity of various protein kinases and phosphatases through redox mechanisms. If oxidative modifications by hydrogen peroxide influence kinases or phosphatases that target DKFZp779B1540, it can lead to its functional activation. | ||||||
Calcium chloride anhydrous | 10043-52-4 | sc-207392 sc-207392A | 100 g 500 g | $66.00 $262.00 | 1 | |
By increasing intracellular calcium levels, calcium chloride can activate calcium-dependent protein kinases. If DKFZp779B1540 is a substrate for such kinases, its activity may be elevated as a result of calcium signaling. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is an inhibitor of protein tyrosine phosphatases. Inhibition of these phosphatases can lead to increased phosphorylation levels of proteins. If DKFZp779B1540 is regulated by tyrosine phosphorylation, its activity could be enhanced due to reduced dephosphorylation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A. Inhibition of these can lead to increased phosphorylation state of proteins. If DKFZp779B1540 is normally regulated by dephosphorylation by these phosphatases, okadaic acid could result in its sustained activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases (SAPKs) such as JNK. If DKFZp779B1540 is a target of JNK or other SAPKs, its activation could be achieved through phosphorylation in response to anisomycin-induced stress signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels, which can activate calcium-dependent signaling pathways. If DKFZp779B1540 is sensitive to calcium-mediated activation, thapsigargin could enhance its activity. | ||||||